logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.

  • Current Page (5)
  • CSV
  • BibTeX
  • EndNote

  • All Results (5)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Implementation of WHO guidelines on urine lateral flow LAM testing in the high TB/HIV burden African countries

Soares KA, Ehrlich J, Camara MS, Chaloub S, Emeka E,  et al.
2023-10-01 • European Respiratory Journal
2023-10-01 • European Respiratory Journal
Journal Article
|
Commentary

Does the type of treatment supporter influence tuberculosis treatment outcomes in Zimbabwe?

Mlilo N, Sandy C, Harries AD, Kumar AMV, Masuka N,  et al.
2013-06-21 • Public Health Action
Journal Article
|
Research
Journal Article
|
Research

Does the type of treatment supporter influence tuberculosis treatment outcomes in Zimbabwe?

Journal Article
|
Research
2013-06-21 • Public Health Action

How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?

Timire C, Takarinda KC, Harries AD, Mutunzi H, Manyame-Murwira B,  et al.
2018-06-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2018-06-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
In Zimbabwe, while the Xpert MTB/RIF assay is being used for diagnosing tuberculosis and rifampicin-resistance, re-treatment tuberculosis (TB) patients are still expected to have culture...
Mlilo N, 
Sandy C, 
Harries AD, 
Kumar AMV, 
Masuka N, 
et al.
2013-06-21 • Public Health Action
2013-06-21 • Public Health Action
Zimbabwe National Tuberculosis Guidelines advise that direct observation of anti-tuberculosis treatment (DOT) can be provided by a family member/relative as a last resort. In 2011, in Nk...

Age-stratified tuberculosis treatment outcomes in Zimbabwe: are we paying attention to the most vulnerable?

Ncube RT, Takarinda KC, Zishiri C, van den Boogaard W, Mlilo N,  et al.
2017-09-01 • Public Health Action
2017-09-01 • Public Health Action
Setting: A high tuberculosis (TB) incidence, resource-limited urban setting in Zimbabwe. Objectives: To compare treatment outcomes among people initiated on first-line anti-tuberculosis ...